• Clinical endocrinology · Mar 2009

    Health-related quality of life in long-term follow-up of patients with cured TNM Stage I or II differentiated thyroid carcinoma.

    • Hanna Pelttari, Harri Sintonen, Camilla Schalin-Jäntti, and Matti J Välimäki.
    • Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
    • Clin. Endocrinol. (Oxf). 2009 Mar 1;70(3):493-7.

    ObjectiveThe purpose of this study was to assess the impact of cured low-risk differentiated thyroid carcinoma (DTC) on health-related quality of life (HRQoL) after long-term follow-up.DesignA cross-sectional study including an age- and gender-standardized sample of the general population.Patients And MethodsHRQoL was assessed by the 15D in 341 DTC patients, whose initial treatment for stage I or II DTC was performed 12.4 years (range 5-20) earlier. The results were compared to those of an age- and gender-standardized sample of the general population (n= 6001). Determinants of HRQoL in DTC patients were assessed by the Tobit model.ResultsMean total 15D scores did not differ between patients and control subjects. In single dimensions, DTC patients were significantly worse off with regards to sleeping, speech and distress (P= 0.001, 0.002 and 0.012, respectively), but better off with regards to discomfort and symptoms (P < 0.001). Within the patient group, the only significant independent predictor of HRQoL was age at the time of the initial treatment (P < 0.001).ConclusionsAfter long-term follow-up, overall HRQoL in DTC patients is comparable to that of the general population. DTC patients demonstrate an age-related decline in HRQoL, similar to that seen in the population in general.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…